Topics in Hyperinsulinism

Friday, October 2, 2026, 8:00 AM - Saturday, October 3, 2026, 3:30 PM, HUB for Clinical Collaboration, Philadelphia, PA


This 2-day symposium will provide comprehensive education on the diagnosis and management of children with hyperinsulinism as well as review exciting advances in the field. The first day will feature lectures on all aspects of hyperinsulinism care and interactive sessions with world-renowned hyperinsulinism experts. The second day offers two tracks: 1) clinically focused activities with simulations, cases, and additional lectures on hyperinsulinism management or 2) research-focused activities with presentations on the latest scientific advances in beta cell biology, genetics, and drug development. The symposium is intended for endocrinologists, neonatologists, surgeons, radiologists, pathologists, and nurses, as well as other providers caring for these complex patients.

1. Discuss the known genetic etiologies of hyperinsulinism and their implications for clinical care and response to therapy.
2. Employ effective strategies to rapidly diagnose hyperinsulinism and initiate treatment.
3. Understand the optimal immediate and long-term management of children with hyperinsulinism to ensure the best outcomes.
4. Review recent research advances in beta cell biology, genetics, and drug development for hyperinsulinism.

In support of improving patient care, this activity has been planned and implemented by the Children’s Hospital of Philadelphia. The Children’s Hospital of Philadelphia is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA PRA Category 1 Credits™ (13.50 hours), ANCC NCPD Contact Hours (13.50 hours), Non-Physician AMA PRA Category 1 Credits™ Attendance (includes PA, RT, RDMS) (13.50 hours)

Mitigation of Relevant Financial Relationships

Children's Hospital of Philadelphia adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.